From 1976 to 1985, 61 consecutive patients with locally advanced breast cancer were treated with multimodality therapy. Overall 5-year survival was 30\% with a median survival of 36 months. 50\% of patients relapsed within 13 months. Other factors such as menopausal status, side of illness (right or left breast), responses to systemic or to local treatment, survival and progression-free survival in responders and non-responders have been analyzed.
Multimodality treatment of locally advanced breast cancer / R., L., P., P., Conte, P., D., A., F., B., G., B., G., C., G., G., R., R.. - In: ONCOLOGY. - ISSN 0030-2414. - STAMPA. - 44:(1987), pp. 137-141. [10.1159/000226463]
Multimodality treatment of locally advanced breast cancer.
CONTE, Pierfranco;
1987
Abstract
From 1976 to 1985, 61 consecutive patients with locally advanced breast cancer were treated with multimodality therapy. Overall 5-year survival was 30\% with a median survival of 36 months. 50\% of patients relapsed within 13 months. Other factors such as menopausal status, side of illness (right or left breast), responses to systemic or to local treatment, survival and progression-free survival in responders and non-responders have been analyzed.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
